These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

627 related items for PubMed ID: 30205933

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Anti-hydroxy-3-methylglutaryl-coenzyme A reductase (anti-HMGCR) antibody in necrotizing myopathy: treatment outcomes, cancer risk, and role of autoantibody level.
    Aggarwal R, Moghadam-Kia S, Lacomis D, Malik A, Qi Z, Koontz D, Burlingame RW, Oddis CV.
    Scand J Rheumatol; 2020 Sep; 49(5):405-411. PubMed ID: 31801390
    [Abstract] [Full Text] [Related]

  • 3. Antibody levels correlate with creatine kinase levels and strength in anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase-associated autoimmune myopathy.
    Werner JL, Christopher-Stine L, Ghazarian SR, Pak KS, Kus JE, Daya NR, Lloyd TE, Mammen AL.
    Arthritis Rheum; 2012 Dec; 64(12):4087-93. PubMed ID: 22933019
    [Abstract] [Full Text] [Related]

  • 4. Statins and myotoxic effects associated with anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase autoantibodies: an observational study in Japan.
    Watanabe Y, Suzuki S, Nishimura H, Murata KY, Kurashige T, Ikawa M, Asahi M, Konishi H, Mitsuma S, Kawabata S, Suzuki N, Nishino I.
    Medicine (Baltimore); 2015 Jan; 94(4):e416. PubMed ID: 25634171
    [Abstract] [Full Text] [Related]

  • 5. Clinical features and prognosis in anti-SRP and anti-HMGCR necrotising myopathy.
    Watanabe Y, Uruha A, Suzuki S, Nakahara J, Hamanaka K, Takayama K, Suzuki N, Nishino I.
    J Neurol Neurosurg Psychiatry; 2016 Oct; 87(10):1038-44. PubMed ID: 27147697
    [Abstract] [Full Text] [Related]

  • 6. Pediatric necrotizing myopathy associated with anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase antibodies.
    Liang WC, Uruha A, Suzuki S, Murakami N, Takeshita E, Chen WZ, Jong YJ, Endo Y, Komaki H, Fujii T, Kawano Y, Mori-Yoshimura M, Oya Y, Xi J, Zhu W, Zhao C, Watanabe Y, Ikemoto K, Nishikawa A, Hamanaka K, Mitsuhashi S, Suzuki N, Nishino I.
    Rheumatology (Oxford); 2017 Feb; 56(2):287-293. PubMed ID: 27818386
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Screening of autoantibodies associated with necrotizing myopathy among undiagnosed chronic myopathy].
    Kuru S, Suzuki S, Ogata K, Kobayashi M, Ishida C, Watanabe C, Matsumura T.
    Rinsho Shinkeigaku; 2017 Oct 27; 57(10):562-566. PubMed ID: 28954975
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Anti-HMGCR antibodies demonstrate high diagnostic value in the diagnosis of immune-mediated necrotizing myopathy following statin exposure.
    Shovman O, Gilburd B, Chayat C, Lazar AD, Amital H, Blank M, Bentow C, Mahler M, Shoenfeld Y.
    Immunol Res; 2017 Feb 27; 65(1):276-281. PubMed ID: 27618830
    [Abstract] [Full Text] [Related]

  • 13. Clinical and genetic associations of autoantibodies to 3-hydroxy-3-methyl-glutaryl-coenzyme a reductase in patients with immune-mediated myositis and necrotizing myopathy.
    Limaye V, Bundell C, Hollingsworth P, Rojana-Udomsart A, Mastaglia F, Blumbergs P, Lester S.
    Muscle Nerve; 2015 Aug 27; 52(2):196-203. PubMed ID: 25521389
    [Abstract] [Full Text] [Related]

  • 14. [Childhood-onset anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase (anti-HMGCR) necrotizing myopathy needs to be distinguished from muscular dystrophy: A case study].
    Hama Y, Mori-Yoshimura M, Komaki H, Suzuki S, Kohsaka H, Nishino I, Takahashi Y.
    Rinsho Shinkeigaku; 2017 Oct 27; 57(10):567-572. PubMed ID: 28966227
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Clinical associations of patients with anti-3-hydroxy-3-methylglutaryl CoA reductase antibody-associated immune-mediated necrotising myopathy.
    Tan E, Knight J, Khonasti S, Nolan D, McGettigan B, Bundell C, Needham M, Brusch A.
    Intern Med J; 2023 Oct 27; 53(10):1846-1853. PubMed ID: 36625419
    [Abstract] [Full Text] [Related]

  • 17. [A case of anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase antibody-positive paraneoplastic necrotizing myopathy associated with advanced gastric cancer that responded to intravenous immunoglobulin therapy].
    Yamaguchi T, Matsunaga A, Ikawa M, Shirafuji N, Nishino I, Hamano T.
    Rinsho Shinkeigaku; 2017 Mar 28; 57(3):118-123. PubMed ID: 28228619
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Association of anti-HMGCR antibodies of the IgM isotype with refractory immune-mediated necrotizing myopathy.
    Yang H, Sun C, Ye L, Xu Y, Lin S, Peng Q, Wang G, Lu X.
    Arthritis Res Ther; 2024 Sep 11; 26(1):158. PubMed ID: 39261921
    [Abstract] [Full Text] [Related]

  • 20. Anti-HMGCR antibodies as a biomarker for immune-mediated necrotizing myopathies: A history of statins and experience from a large international multi-center study.
    Musset L, Allenbach Y, Benveniste O, Boyer O, Bossuyt X, Bentow C, Phillips J, Mammen A, Van Damme P, Westhovens R, Ghirardello A, Doria A, Choi MY, Fritzler MJ, Schmeling H, Muro Y, García-De La Torre I, Ortiz-Villalvazo MA, Bizzaro N, Infantino M, Imbastaro T, Peng Q, Wang G, Vencovský J, Klein M, Krystufkova O, Franceschini F, Fredi M, Hue S, Belmondo T, Danko K, Mahler M.
    Autoimmun Rev; 2016 Oct 11; 15(10):983-93. PubMed ID: 27491568
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.